The EconomistFebruary 24th 2018 Science and technology 69
1
2
C
ALCULATING machines that run on
quantum bits (known asqubits, for
short) are, by some accounts, the future of
computation. Quantum computers have
the theoretical advantage that they can
solve with ease certain mathematical pro-
blems, such as the factorisation of large
numbers, which are hard or impossible for
classical machines. This is possible thanks
to a qubit’s ability to remain, through the
peculiarities of quantum mechanics, in
many quantum states simultaneously. The
more qubits a computer has, the more
mind-bogglingly gigantic are the calcula-
tions it can handle. Finance, medicine,
chemistry and artificial intelligence are
thus all expected to be transformed by
quantum computing.
And where the future is, there surely
will Google be also. The firm sets great
store by its quantum-computing project,
which it calls Project Bristlecone. This is in-
tended to develop a “quantum-supremacy
device”, ie, one that is palpably and prov-
ably faster than a traditional computer of
equivalent size atsolving particular math-
ematical problems. Google is currently
preparing such a device, which will have
49 qubits. Itis rumoured thatthis will be
ready for demonstration before the year is
out. Though not confirming such rumours,
John Martinis, Google’s quantum-comput-
ing boss, told the AAASmeeting about
some of the problems involved in doing so.
Leadership in the quantum-computing
race, Dr Martinis said, is typically mea-
sured in terms of the number of qubits that
a machine can handle. Less attention is
paid to those machines’ error rates. Since
the people building such experimental
machines are usually physicists, rather
than engineers, they typically cite their
best measurementswhen reportingqubit
error rates, in order to show the machine’s
capability. That number is of little interest
to Dr Martinis and his team, though. They
are thinking like engineers, attempting to
build a robust, working device. In this case,
Dr Martinis says, it is the worst error, not
the slightest, that is important.
Project Bristlecone’s main concern is
the quality ofthe qubits. The theoretical
ability to beat a classical computer is of lit-
tle use if the hardware that serves as the
physical representations of those calcula-
tions is misfiring or dodgy.
At the moment, that is sometimes the
case. Preparing and maintainingqubits is a
delicate and fiddly process, akin to classi-
Quantum computing
Quality over
quantity
AUSTIN
If quantum computers are to be useful,
they must first be reliable
A
ROUND 1936 three neurologists atHar-
vard Medical School raided the medi-
cine cabinet, filling their boots with mor-
phine, barbiturates, ethers and even cobra
venom. They injected those substances
into (apparently) willing volunteers and
cemented primitive electrodes to their
scalps and earlobes. They also collared a
drunk and wired him up. With pen and pa-
per, they then recorded how the electrical
signals in their volunteers’ brains changed
as the drugs began to take hold.
This kind of gonzo science might meet a
touch of resistance from the institutional
review board if proposed today, but the
work of Gibbs, Gibbs and Lennox still
stands. The trio showed, without meaning
to, that sedatives lower the activity of the
brain through several clear stages, and that
each stage is observable in that organ’s
electrical readings. Their results have been
refined over the years, of course, to the ex-
tent that Emery Brown, a successor of
theirs at Harvard, now thinks, as he told
the AAASmeeting, that statistical analysis
of such electroencephalography (EEG) sig-
nals has become so good that it can be used
to make anaesthesia safer and better.
The EEG of a conscious brain shows no
striking features, just low-amplitude and
seemingly uncorrelated ups and downs in
the frequency of oscillations in the brain’s
electric field. That is because the brain’s
neurons are firing independently of one
another as they go about the various tasks
that render their owner conscious. Then
(as the Harvard trio found) as the patient
goes under the oscillations smooth out,
deepening into a stark, uniform wave
which vibrates ten times a second. The
drug has tripped the neurons into singing
from the same hymn sheet. Their unified
song takes over from the cacophony of a
conscious brain, and the patient is out.
That, Dr Brown believes, gives anaes-
thetists a better way to assess how deeply
someone is under than measuring blood
pressure and heart rate. He regularly uses
brain waves clinically. In a recent opera-
tion, for example, he was able to adminis-
ter a third of the normal dose of an anaes-
thetic called propofol to an 81-year-old
cancer patient, monitoring her brain
waves to ensure that she was deeply under
at all times. Indeed, he thinks he may be
able to automate the whole process, and
has designed a machine which adjusts the
dose in response to brainwave changes.
He also believes that the potential for
using EEG to understand unconscious
brainwaves goes beyond the operating ta-
ble. Sleeping pills, for instance, do not so
much aid sleep as sedate their recipient. Dr
Brown thinks insomniacs might be guided
into true sleep through a more precise ex-
amination of their brain activity, and the
application of commensurate drugs.
Moreover, true successor to Gibbs,
Gibbs and Lennox that he is, Dr Brown re-
veals his own gonzo side when he says his
understanding ofEEGreadouts is such that
he believes he could safely place someone
into, and then retrieve him from, a
“locked-in” state—one in which a person is
fully aware of his surroundings, but inca-
pable of any movement or action. When
your correspondent offered himself as a
test subject, only partially in jest, Dr Brown
flashed an arch grin, before sombrely ex-
plaining that such an experiment would
be beyond the tolerance of modern review
boards, too. 7
Unconsciousness
Going under
AUSTIN
Tracking the brain’s electrical activity
can make anaesthesia safer
Watching the waves
tem, including the heart. Dr Garry, too, is
then able to persuade human stem cells to
grow into organ cells—in his case heart
cells—though at the moment they form
only a small proportion of the cells in the
resultant embryonic hearts.
In their quests for pancreatic cells, Dr
Nakauchi and Dr Ross have encountered
similar problems of rarity. But these are
early days. Dr Garry, whose laboratory is
now producing two or three pig-human fe-
tuses a week, is studying those fetuses to
try to understand why it is that in some
only one heart cell in 100,000 is human
while in other fetuses the number is one in
- If he can discoverthe underlying prin-
ciple, then the aim of replacing pig cardiac
cells entirely with human ones will have
come closer. 7